CSL Limited - Financial and Strategic Analysis Review

CSL Limited - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of "CSL Limited". The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

CSL Limited (CSL) is a global biopharmaceutical company, focused on the research, development, manufacture, marketing and distribution of pharmaceutical products. The company operates through three segments namely, CSL Behring, Intellectual Property Licensing and Other Human Health. Its areas of expertise include plasma products, vaccines and pharmaceuticals and research and development. CSL holds almost 90 years experience of experience in the development and manufacture of vaccines and plasma protein biotherapies. It operates in over 27 countries and has its major facilities located in Germany, Australia, Switzerland and the US. The company is headquartered in Victoria, Australia.

And More inside the report…

Recent Developments

Jan 28, 2010: Patrys Collaborates With CSL For Antibody Drugs
Dec 22, 2009: CSL Reports Results For Swine Flu Vaccine Trial In Children
Nov 11, 2009: CSL Biotherapies’ Influenza A (H1N1) 2009 Monovalent Vaccine Receives FDA Licensure

Scope

- Provides key company information for business intelligence needs
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive and/or technological threats are highlighted.
- The report contains critical company information – business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last fourinterim periods.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

- A quick "one-stop-shop" to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial & strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers – with key data on their businesses and locations.
- Capitalize on competitors’ weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.